Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, August 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
The Hiden HMT Vacuum Process Diagnostic
Saturday, August 16, 2014
Monitoring by Faraday detector at high pressure and at lower pressures by electron multiplier detector.

High Temperature/Pressure Sampling with the Hiden QIC-Series
Wednesday, August 06, 2014
Designed specifically for in-process gas analysis.

Bio-Rad Introduces SureBeads™ Magnetic Bead IP System
Thursday, July 31, 2014
A high-performance immunoprecipitation system at an affordable price.

AB SCIEX Announces the 4500MD Series* for In Vitro Diagnostic Use
Tuesday, July 29, 2014
Industry leader increases mass spectrometry portfolio for clinical testing laboratories.

The Hiden EQP Plasma Diagnostic with On-board MCA
Tuesday, July 22, 2014
A pure research tool specifically derived and enhanced for the plasma researcher.

Vanquish UHPLC sees Thermo Fisher Scientific Reimagine UHPLC
Tuesday, July 15, 2014
Thermo Fisher Scientific has unveiled a new high performance liquid chromatography system designed from the ground up to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers.

Hiden HPR-40 Membrane Inlet Dissolved Gas Monitor
Thursday, July 03, 2014
Measurement of dissolved gases and vapours in aqueous solution.

Agilent Technologies and PREMIER Biosoft Couple Hardware-Software Platforms to Advance Glycomics Research
Tuesday, July 01, 2014
Complementary Technologies Maximize Analytical Capabilities, Enable Researchers to Advance Discovery in Cancer, Other Complex Diseases

Biotage Launches ACI™ - Accelerated Chromatographic Isolation
Monday, June 30, 2014
Biotage announces the launch of ACI™ (Accelerated Chromatographic Isolation), a new advance converting simple flash purification into a faster and more economical way to isolate pure compounds.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1091
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv